Category: PMCPA Case of the Week

Cases selected for the AskAnzal weekly PMCPA insight newsletter

8 Mar 2026

ALK-AbellΓ³: Jext formulary materialsβ€”misleading β€œ33% longer shelf-life” claim (AUTH/2387/2/11)

Formulary pack/template for Jext claimed β€œ33% longer shelf-life”. Panel said wording implied patients would receive a full 24…

8 Mar 2026

AUTH/2443/10/11: Anonymous v Genus Pharmaceuticals β€” conduct of Apo-go nurse advisor (No breach)

Anonymous pharmacist alleged an Apo-go nurse advisor changed Parkinson’s medicines without authority and failed to inform PDNSs. Panel…

8 Mar 2026

Pfizer breached ABPI Code over Prevenar 13 leavepiece implying a β€œnew indication” in HIV (AUTH/2483/2/12)

A Prevenar 13 leavepiece prominently linked HIV to a β€œNew Indication”, implying a licensed HIV indication and omitting…

8 Mar 2026

Almirall meeting invitation for Eklira Genuair: PMCPA found it was clearly promotional (no breach)

A pharmacist said an Almirall COPD guidelines meeting invite blurred education vs promotion. PMCPA ruled the invite/meeting were…

8 Mar 2026

AUTH/2789/8/15: Roche/PMCPA Director v Merck Serono β€” CDF presentation alleged to breach undertaking (No breach)

Roche alleged Merck Serono breached a prior PMCPA undertaking via a Cancer Drugs Fund presentation of Erbitux trial…

8 Mar 2026

AUTH/2713/5/14: Chief Pharmacist v Eli Lilly β€” Strattera nurse speaker engagement (No breach)

An NHS chief pharmacist alleged a Strattera nurse speaker contract looked like inducement/seeding research and queried disclosure. PMCPA…

8 Mar 2026

AUTH/2919/12/16: Anonymous (non-contactable) v Merck Sharp & Dohme β€” no breach (representative conduct allegation)

Anonymous GP alleged an MSD representative brought her daughter to meetings. MSD found no record of any complaint.…

8 Mar 2026

Sanofi breached ABPI Code over Toujeo β€œLatest Data” app implying hypoglycaemia benefit from clamp-study PK/PD data (AUTH/2951/4/17)

Toujeo iPad β€œLatest Data” app design and training encouraged linking clamp-study PK/PD variability data to reduced hypoglycaemia. Panel…

8 Mar 2026

AUTH/1962/2/07: PCT adviser v AstraZeneca – Symbicort budget impact model presented to practice managers (no breach)

A PCT adviser challenged AstraZeneca’s Symbicort budget impact presentation to GP practice managers and meeting sponsorship. Panel found…

8 Mar 2026

PMCPA AUTH/3006/12/17: Director v Lilly (Trulicity) – clinical trial disclosure

PMCPA case AUTH/3006/12/17 (Director v Lilly) concerning clinical trial disclosure for Trulicity. Outcome: No breach; matter was outwith…

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training